Copyright
©The Author(s) 2025.
World J Clin Cases. Aug 16, 2025; 13(23): 101742
Published online Aug 16, 2025. doi: 10.12998/wjcc.v13.i23.101742
Published online Aug 16, 2025. doi: 10.12998/wjcc.v13.i23.101742
Table 1 Clinical information of the training and validation cohorts, n (%)/mean ± SD
Characteristics | Training cohort (n = 85) | Validation cohort (n = 37) | P value |
Sex | 0.430 | ||
Male | 73 (85.9) | 33 (89.2) | |
Female | 12 (14.1) | 4 (10.8) | |
Age | 54.35 ± 10.930 | 57.43 ± 10.219 | 0.147 |
Child-Pugh class | 0.213 | ||
A | 67 (78.8) | 26 (70.3) | |
B | 18 (21.2) | 11 (29.7) | |
Hepatitis | 0.040 | ||
None | 4 (4.7) | 1 (2.7) | |
Hepatitis B | 79 (92.9) | 32 (86.5) | |
Hepatitis C | 1 (1.2) | 1 (2.7) | |
Alcoholic hepatitis | 1 (1.2) | 3 (8.5) | |
PT (s) | 0.458 | ||
≤ 14 | 80 (94.1) | 34 (91.9) | |
> 14 | 5 (5.9) | 3 (8.1) | |
TB (μmol/L) | 0.173 | ||
≤ 17.1 | 41 (48.2) | 22 (59.5) | |
> 17.1 | 44 (51.8) | 15 (40.5) | |
ALB (g/L) | 0.144 | ||
≤ 35 | 45 (52.9) | 15 (40.5) | |
> 35 | 40 (47.1) | 22 (59.5) | |
AST (U/L) | 0.357 | ||
≤ 40 | 18 (21.2) | 6 (16.2) | |
> 40 | 67 (78.8) | 31 (83.8) | |
ALT (U/L) | 0.194 | ||
≤ 50 | 59 (69.4) | 22 (59.5) | |
> 50 | 26 (30.6) | 15 (40.5) | |
AFP (ng/mL) | 0.326 | ||
≤ 400 | 27 (31.8) | 14 (37.8) | |
> 400 | 58 (68.2) | 23 (62.2) |
- Citation: Zhao KF, Xie CB, Wu Y. Prediction of the efficacy of first transarterial chemoembolization for advanced hepatocellular carcinoma via a clinical-radiomics model. World J Clin Cases 2025; 13(23): 101742
- URL: https://www.wjgnet.com/2307-8960/full/v13/i23/101742.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i23.101742